Lataa...
Precision medicine and personalized breast cancer: combination pertuzumab therapy
Trastuzumab (Herceptin), a monoclonal antibody directed against the human epidermal growth-factor receptor 2 (HER2), is the poster child for antibody-based targeted therapy in breast cancer. Pertuzumab, another humanized monoclonal antibody, binds to a different domain of HER2 and prevents the forma...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3977457/ https://ncbi.nlm.nih.gov/pubmed/24715764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S37100 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|